Literature DB >> 9054742

Role of compensatory enlargement and shrinkage in transplant coronary artery disease. Serial intravascular ultrasound study.

T T Lim1, D H Liang, J Botas, J S Schroeder, S N Oesterle, A C Yeung.   

Abstract

BACKGROUND: Compensatory enlargement of the vessel wall has been described in the early stages of native atherosclerosis. Whether compensatory enlargement plays a role in transplant coronary artery disease is not known. The objective of this study was to determine, by use of serial intravascular ultrasound (IVUS), whether compensatory dilation occurs in transplant coronary artery disease over time. METHODS AND
RESULTS: Seventy-five heart transplant recipients with 151 matched coronary segments were selected for the presence of intimal disease progression as detected by serial IVUS examinations 1 to 3 years apart. Intimal disease progression was defined as a > 10% increase in intimal area (IA). IVUS catheter location in follow-up studies was verified angiographically in relation to branch vessels. Luminal area (LA) and total vessel area (TA) were measured at each site. Intimal area (IA = TA-LA) was calculated. Changes in IA (delta IA) and TA (delta TA) between baseline and follow-up IVUS were compared: delta IA, 2.9 +/- 0.2 mm2: delta TA, 2.7 +/- 0.4 mm2. A remodeling index (RI) was defined as RI = delta TA/delta IA. Three subgroups could be distinguished: over compensation (RI > I), partial compensation (RI 0 to 1), and no compensation or shrinkage (RI < or = 0). Seventy-four segments (49%) showed overcompensation, 44 (29%) showed partial compensation, and 33 (22%) showed no compensation or shrinkage.
CONCLUSIONS: In this study, serial IVUS shows that early after cardiac transplantation, a large proportion of the coronary segments with progression of intimal thickening have compensatory dilation of the vessel wall. However, a substantial number of coronary segments (22%) show no compensatory dilation or shrinkage. The progressive luminal narrowing in transplant patients may be due in part to vessel shrinkage or the lack of compensatory dilation over time.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9054742     DOI: 10.1161/01.cir.95.4.855

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  11 in total

1.  Assessment of coronary compensatory enlargement by three-dimensional intravascular ultrasound.

Authors:  J D Klingensmith; D G Vince; B D Kuban; R Shekhar; E M Tuzcu; S E Nissen; J F Cornhill
Journal:  Int J Card Imaging       Date:  2000-04

Review 2.  The pathobiology of the vessel wall: implications for imaging.

Authors:  Mehran M Sadeghi
Journal:  J Nucl Cardiol       Date:  2006 May-Jun       Impact factor: 5.952

Review 3.  How to standardize vasomotor tone in serial studies based on quantitation of coronary dimensions?

Authors:  S Jost; C W Nolte; M Sturm; J Hausleiter; D Hausmann
Journal:  Int J Card Imaging       Date:  1998-12

Review 4.  Cardioprotective mechanisms of ACE inhibition. The angiotensin II-nitric oxide balance.

Authors:  G H Gibbons
Journal:  Drugs       Date:  1997       Impact factor: 9.546

5.  Progression of cardiac allograft vascular disease as assessed by serial intravascular ultrasound: correlation to immunological and non-immunological risk factors.

Authors:  K Pethig; V Klauss; B Heublein; H Mudra; A Westphal; C Weber; K Theisen; A Haverich
Journal:  Heart       Date:  2000-11       Impact factor: 5.994

6.  Arterial remodelling of native human coronary arteries in patients with unstable angina pectoris: a prospective intravascular ultrasound study.

Authors:  M Gyöngyösi; P Yang; A Hassan; F Weidinger; H Domanovits; A Laggner; D Glogar
Journal:  Heart       Date:  1999-07       Impact factor: 5.994

Review 7.  What has intravascular ultrasound taught us about plaque biology?

Authors:  S Kinlay
Journal:  Curr Atheroscler Rep       Date:  2001-05       Impact factor: 5.113

8.  Donor-specific antibodies to class II antigens are associated with accelerated cardiac allograft vasculopathy: a three-dimensional volumetric intravascular ultrasound study.

Authors:  Yan Topilsky; Manish J Gandhi; Tal Hasin; Laurie L Voit; Eugenia Raichlin; Barry A Boilson; John A Schirger; Brooks S Edwards; Alfredo L Clavell; Richard J Rodeheffer; Robert P Frantz; Sudhir S Kushwaha; Amir Lerman; Naveen L Pereira
Journal:  Transplantation       Date:  2013-01-27       Impact factor: 4.939

Review 9.  Cardiac allograft vasculopathy: the Achilles' heel of long-term survival after cardiac transplantation.

Authors:  Amandeep Dhaliwal; Vinay Thohan
Journal:  Curr Atheroscler Rep       Date:  2006-03       Impact factor: 5.113

10.  Combined heart and liver transplant attenuates cardiac allograft vasculopathy compared with isolated heart transplantation.

Authors:  Yan Topilsky; Eugenia Raichlin; Tal Hasin; Barry A Boilson; John A Schirger; Naveen L Pereira; Brooks S Edwards; Alfredo L Clavell; Richard J Rodeheffer; Robert P Frantz; Manish J Gandhi; Simon Maltais; Soon J Park; Richard C Daly; Amir Lerman; Sudhir S Kushwaha
Journal:  Transplantation       Date:  2013-03-27       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.